Diverse biological actions of atrial natriuretic peptide.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Physiological Reviews

• Publication date

  1990-07-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1152/PHYSREV.1990.70.3.665PMID 2141944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radioautographic localization of125I-atrial natriuretic fator (ANF) in rat tissues

  2006cited by this paper
• Immunohistochemical localization of cardiodilatin in myoendocrine cells of the cardiac atria

  2004cited by this paper
• Brain natriuretic peptide: interaction with renal ANP system.

  1990cited by this paper
• Dopamine1-receptor blockade inhibits ANP-induced phosphaturia and calciuria in rats.

  1990cited by this paper
• ANF inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney.

  1989cited by this paper
• Role of ANP in natriuresis of head-out immersion in humans.

  1989cited by this paper
• Effects of converting-enzyme inhibitor on hemodynamic actions of ANP in renal hypertensive rats.

  1989cited by this paper
• Hyposecretion of Atrial Natriuretic Factor by Prehypertensive Dahl Salt‐Sensitive Rat

  1989cited by this paper
• Clearance function of type C receptors of atrial natriuretic factor in rats.

  1989cited by this paper
• Enhanced release of atrial natriuretic factor by endothelin in atria from hypertensive rats.

  1989cited by this paper
• Effect of ANP on circulating blood volume.

  1989cited by this paper
• The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family.

  1989cited by this paper
• Enkephalinase Inhibition Increases Plasma Atrial Natriuretic Peptide Levels, Glomerular Filtration Rate, and Urinary Sodium Excretion in Rats With Reduced Renal Mass

  1989cited by this paper
• Atrial Natriuretic Factor in Hypertension: Bioactivity at Normal Plasma Levels

  1989cited by this paper
• Atrial natriuretic peptide inhibits a cation channel in renal inner medullary collecting duct cells.

  1989cited by this paper
• Mechanisms of hypoxia-induced atrial natriuretic factor release from rat hearts.

  1989cited by this paper
• Characteristics of ANP-sensitive guanylate cyclase in inner medullary collecting duct cells.

  1989cited by this paper
• Atrial peptide potentiates renal responses to volume expansion in conscious dogs.

  1989cited by this paper
• Role of atrial peptide in the natriuresis and diuresis that follows relief of obstruction in rat.

  1989cited by this paper
• Normal atrial natriuretic peptide release after acute and chronic stimuli in hypophysectomized rats.

  1989cited by this paper
• Regulation of Na-K-Cl cotransport in endothelial cells by atrial natriuretic factor.

  1989cited by this paper
• The protein kinase domain of the ANP receptor is required for signaling.

  1989cited by this paper
• Ventricles as a Major Site of Atrial Natriuretic Factor Synthesis and Release in Cardiomyopathic Hamsters With Heart Failure

  1989cited by this paper
• A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor

  1989cited by this paper
• Effects of water immersion on atrial natriuretic peptide release in humans.

  1989cited by this paper
• Effect of nicardipine and atriopeptin on transcapillary shift of fluid and proteins.

  1989cited by this paper
• Mechanism of inhibition of renin response to hypotension by atrial natriuretic factor.

  1989cited by this paper
• Calcium, Its Role in Isoproterenol-Stimulated Atrial Natriuretic Peptide Secretion by Superfused Rat Atria

  1989cited by this paper
• Atrial natriuretic peptide response to rapid atrial pacing in cardiac-denervated dogs.

  1989cited by this paper
• Permissive role of dopamine in renal action of ANP in volume-expanded rats.

  1989cited by this paper
• Atrial natriuretic peptide and nitroprusside cause relaxation of cultured rat mesangial cells.

  1989cited by this paper
• Chronic blockade of endogenous atrial natriuretic polypeptide (ANP) by monoclonal antibody against ANP accelerates the development of hypertension in spontaneously hypertensive and deoxycorticosterone acetate-salt-hypertensive rats.

  1989cited by this paper
• Effects of ANP on venous pressures and microvascular protein permeability in dog forelimb.

  1989cited by this paper
• Endothelin stimulates release of atrial natriuretic peptides in vitro and in vivo.

  1989cited by this paper
• Endothelium-dependent vascular responses. Mediators and mechanisms.

  1989cited by this paper
• Role of endogenous atrial natriuretic peptide in congestive heart failure.

  1989cited by this paper
• The effects of atrial peptide in humans with chronic renal failure.

  1989cited by this paper
• Blunted excretory response to atrial natriuretic peptide in experimental nephrosis.

  1989cited by this paper
• Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases

  1989cited by this paper
• Escape from the sodium-retaining effects of mineralocorticoids: role of ANF and intrarenal hormone systems.

  1989cited by this paper
• Expression and regulation of ANP receptor subtypes in rat renal glomeruli and papillae.

  1989cited by this paper
• Potentiation of renal effects of atrial natriuretic factor-(99-126) by SQ 29,072.

  1989cited by this paper
• Atrial natriuretic factor gene expression in rat ventricle during experimental hypertension.

  1989cited by this paper
• Effect of atrial natriuretic factor on calcium fluxes in adrenal glomerulosa cells.

  1988cited by this paper
• Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart failure.

  1988cited by this paper
• Effects of atrial natriuretic factor and vasopressin on cyclic nucleotides in cultured kidney cells.

  1988cited by this paper
• Hormone effects on NaCl permeability of rat inner medullary collecting duct.

  1988cited by this paper
• Acute effects of peritoneovenous shunting on plasma atrial natriuretic peptide in cirrhotic patients with massive refractory ascites.

  1988cited by this paper
• Direct evaluation of the microvascular actions of ANP in juxtamedullary nephrons.

  1988cited by this paper
• Effect of atrial natriuretic peptide on ACTH, dibutyryl cAMP, angiotensin II and potassium-stimulated aldosterone secretion by rat adrenal glomerulosa cells.

  1988cited by this paper
• Micropuncture study of the effect of ANP on the papillary collecting duct in the rat.

  1988cited by this paper
• Regulation of aldosterone secretion.

  1988cited by this paper
• Effect of atrial natriuretic factor on renal function in rats with nephrotic syndrome.

  1988cited by this paper
• Glomerular and Vascular Atrial Natriuretic Factor Receptors in Saralasin‐Sensitive and Resistant Two‐Kidney, One‐Clip Hypertensive Rats

  1988cited by this paper
• Characterization and regulation by protein kinase C of renal glomerular atrial natriuretic peptide receptor-coupled guanylate cyclase.

  1988cited by this paper
• Plasma atrial natriuretic peptide in essential hypertension. Comparison with normotensive subjects and effects of changes in dietary sodium intake.

  1988cited by this paper
• Regulation of the plasma membrane Ca2+ pump by cyclic nucleotides in cultured vascular smooth muscle cells.

  1988cited by this paper
• Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.

  1988cited by this paper
• Phosphorylation of a single subunit of the epithelial Na+ channel protein following vasopressin treatment of A6 cells.

  1988cited by this paper
• Effect of alpha- and beta-adrenergic stimulation on atrial natriuretic peptide release in vitro.

  1988cited by this paper
• Effects of a physiological dose of ANP on renal function in dogs.

  1988cited by this paper
• Endothelin is a potent secretagogue for atrial natriuretic peptide in cultured rat atrial myocytes.

  1988cited by this paper
• Long-term hemodynamic actions of atrial natriuretic factor (99-126) in conscious sheep.

  1988cited by this paper
• Hemodynamic and renal effects of low-dose infusions of atrial peptide in awake dogs.

  1988cited by this paper
• Is atriopeptin a physiological or pathophysiological substance? Studies in the autoimmune rat.

  1988cited by this paper
• A highly sensitive radioreceptor assay for atrial natriuretic peptide in rat plasma.

  1988cited by this paper
• ANF secretion and renal responses to volume expansion with equilibrated blood.

  1988cited by this paper
• Atrial natriuretic peptides inhibit conductive sodium uptake by rabbit inner medullary collecting duct cells.

  1988cited by this paper
• The role of cyclic nucleotides in atrial natriuretic peptide-mediated inhibition of aldosterone secretion.

  1988cited by this paper
• Atrial natriuretic peptide inhibits the stimulation of aldosterone secretion but not the transient increase in intracellular free calcium concentration induced by angiotensin II addition.

  1988cited by this paper
• Atrial natriuretic factor gene expression in ventricles of rats with spontaneous biventricular hypertrophy.

  1988cited by this paper
• Guanosine 3',5'-cyclic monophosphate as a mediator of inhibition of renin release.

  1988cited by this paper
• Cyclic nucleotide-dependent protein kinase inhibition by H-8: effects on ion transport.

  1988cited by this paper
• Identification of protease 3.4.24.11 as the major atrial natriuretic factor degrading enzyme in the rat kidney.

  1988cited by this paper
• Atrial Natriuretic Factor Regulates the Calcium Current in Frog Isolated Cardiac Cells

  1988cited by this paper
• Role of atrial pressure and rate in release of atrial natriuretic peptide.

  1988cited by this paper
• Atrial natriuretic factor does not inhibit basal or angiotensin II-stimulated proximal transport.

  1988cited by this paper
• Effect of synthetic human atrial natriuretic peptide (102-126) in nephrotic syndrome.

  1988cited by this paper
• Role of atrial natriuretic peptide in the natriuretic response to central volume expansion induced by head-out water immersion in sodium-retaining cirrhotic subjects.

  1988cited by this paper
• Blunted cGMP response to ANF in vascular smooth muscle cells of SHR.

  1988cited by this paper
• Atrial natriuretic peptide and furosemide effects on hydraulic pressure in the renal papilla.

  1988cited by this paper
• Atrial natriuretic factor inhibits vasopressin-stimulated osmotic water permeability in rat inner medullary collecting duct.

  1988cited by this paper
• Involvement of Ni protein in the functional coupling of the atrial natriuretic factor (ANF) receptor to adenylate cyclase in rat lung plasma membranes.

  1988cited by this paper
• Amiloride-sensitive cation channel in apical membrane of inner medullary collecting duct.

  1988cited by this paper
• A new natriuretic peptide in porcine brain

  1988cited by this paper
• Impaired response of atrial natriuretic factor to high salt intake in persons prone to hypertension.

  1988cited by this paper
• Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones.

  1988cited by this paper
• Interaction of atriopeptin III and vasopressin on calcium kinetics and contraction of aortic smooth muscle cells.

  1988cited by this paper
• Atrial natriuretic peptide and the renal response to hypervolemia in nephrotic humans.

  1988cited by this paper
• Specific binding of atrial natriuretic factor to renal glomeruli in Doca- and Doca-salt-treated rats correlation with atrial and plasma levels.

  1987cited by this paper
• Thick ascending limb response to dDAVP and atrial natriuretic factor in vivo.

  1987cited by this paper
• Atriopeptin III alters renal medullary hemodynamics and the pressure-diuresis response in rats.

  1987cited by this paper
• Down-regulation of atrial natriuretic peptide receptor and cyclic GMP response in cultured rat vascular smooth muscle cells.

  1987cited by this paper
• Identification of the primary translation product of atrial natriuretic peptide receptor mRNA in a cell-free system using anti-receptor antiserum.

  1987cited by this paper
• Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function.

  1987cited by this paper
• Amino acid sequence of atrial natriuretic peptides in human coronary sinus plasma.

  1987cited by this paper
• Direct inhibitory effect of atriopeptin III on renin release in primate kidney.

  1987cited by this paper
• Inhibition of the firing of vasopressin neurons by atriopeptin

  1987cited by this paper
• Regulation of atrial natriuretic peptide receptors in the rat brain

  1987cited by this paper
• Atrial natriuretic peptide receptors along the rat and rabbit nephrons: [125I] α-rat atrial natriuretic peptide binding in microdissected glomeruli and tubules

  1987cited by this paper

• Mentoring at a distance: Atrial peptides, the inner medullary collecting duct, Barry Brenner and me.

  2026cites this paper
• Fluid management strategies in critically ill patients with ARDS: a narrative review

  2025cites this paper
• Cardiorenal Syndrome and Autonomic Overactivity

  2025cites this paper
• The Balance Between the Natriuretic Peptides and the Renin-Angiotensin-Aldosterone System in the Preservation of Ideal Cardiovascular Health

  2025cites this paper
• Association Between Vitamin D Status and Nocturnal Lower Urinary Tract Symptoms: A Pooled Analysis.

  2025cites this paper
• Predicting cardiac and renal responses to sacubitril/valsartan with a mathematical model of heart failure with preserved ejection fraction.

  2025cites this paper
• Ghrelin suppresses water intake with a different physiological significance from atrial natriuretic peptide in conscious seawater-acclimated eels.

  2025cites this paper
• Podocyte cell-specific Npr1 is required for blood pressure and renal homeostasis in male and female mice: role of sex-specific differences

  2024cites this paper
• Multilimbed membrane guanylate cyclase signaling system, evolutionary ladder

  2023cites this paper
• Sodium Homeostasis, a Balance Necessary for Life

  2023cites this paper
• Comparative efficacy and safety of sodium–glucose cotransporter 2 inhibitors for renal outcomes in patients with type 2 diabetes mellitus: a systematic review and network meta-analysis

  2023cites this paper
• A spatiotemporal gene expression and cell atlases of the developing rat ovary

  2023cites this paper
• Blood Pressure in Children with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

  2023cites this paper
• C-type natriuretic peptide (CNP) in the paraventricular nucleus-mediated renal sympatho-inhibition

  2023cites this paper
• Guanylyl cyclase/natriuretic peptide receptor-A: Identification, molecular characterization, and physiological genomics

  2023cites this paper
• Atrial natriuretic peptide in the prevention of acute renal dysfunction after heart transplantation—a randomized placebo‐controlled double‐blind trial

  2023cites this paper
• Natriuretic Peptide Signaling in Uterine Biology and Preeclampsia

  2023cites this paper
• Responses in Blood Pressure and Kidney Function to Soluble Guanylyl Cyclase Stimulation or Activation in Normal and Diabetic Rats

  2022cites this paper
• Natriuretic peptide receptors in the kidneys are predominantly vascular and not tubular

  2022cites this paper
• Anti-cancer peptide-based therapeutic strategies in solid tumors

  2022cites this paper
• Purification, characterization, and preliminary serial crystallography diffraction advances structure determination of full-length human particulate guanylyl cyclase A receptor

  2022cites this paper
• Modulation of atrial natriuretic peptide receptors in ovarian folliculogenesis

  2022influential citation
• Nanoemulsions for the Delivery of Anti-Hypertensive Drugs

  2022cites this paper
• Type 2 diabetes mellitus, interaction between left ventricle and large arteries.

  2022cites this paper
• Comparison of ANP and BNP Granular Density in Atria of Rats After Physiological and Pathological Hypertrophy

  2022cites this paper
• Downregulation of Natriuretic peptide receptor-C in Vascular smooth muscle cells from Spontaneously hypertensive rats contributes to Vascular Remodeling.

  2022cites this paper
• Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology

  2022cites this paper
• Atrial Natriuretic Peptide (ANP) Regulates the Biological Activity of EGF/EGFR System in Adult Retinal Pigment Epithelial Cell

  2021cites this paper
• Atrial natriuretic peptide

  2021cites this paper
• Hemodynamic phenotyping of transgenic rats with ubiquitous expression of an angiotensin-(1-7)-producing fusion protein.

  2021cites this paper
• Guanylin Peptides Signaling: Insights into Guanylate Cyclase C Dependent and Independent Signaling Pathways

  2021cites this paper
• Natriuretic peptide family

  2021cites this paper
• Atrial Natriuretic Peptide31–67: A Novel Therapeutic Factor for Cardiovascular Diseases

  2021cites this paper
• Evolution of the membrane/particulate guanylyl cyclase: from physicochemical sensors to hormone receptors.

  2021cites this paper
• Atrial natriuretic peptide does not degrade the endothelial glycocalyx: A secondary analysis of a randomized porcine model

  2021cites this paper
• Role of natriuretic peptides in the cardiovascular-adipose communication: a tale of two organs

  2021cites this paper
• In silico trial of baroreflex activation therapy for the treatment of obesity-induced hypertension

  2021cites this paper
• Protection of kidney function and tissue integrity by pharmacologic use of natriuretic peptides and neprilysin inhibitors

  2021cites this paper
• Atrial Natriuretic Peptide: Structure, Function, and Physiological Effects: A Narrative Review

  2021cites this paper
• Molecular Signaling Mechanisms and Function of Natriuretic Peptide Receptor-A in the Pathophysiology of Cardiovascular Homeostasis

  2021cites this paper
• Protective Renal Effects of Atrial Natriuretic Peptide: Where Are We Now?

  2021cites this paper
• Investigation of Atrial Natriuretic Peptide as A Competitive Inhibitory Candidate Against Wnt/β-Catenin Signalling: A Molecular Dynamics Approach

  2020cites this paper
• Normal Physiology of Renal System

  2020cites this paper
• Brain and Kidney Crosstalk

  2020cites this paper
• Short-term Renoprotective Effect of SGLT-2 Inhibitor for Renal Function and Albuminuria in Type 2 Diabetes: a Retrospective Study

  2020cites this paper
• Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes

  2020cites this paper
• Impact of Sacubitril-Valsartan on Markers of Glomerular Function

  2020cites this paper
• Renal, Cardiovascular, and Safety Outcomes of Canagliflozin by Baseline Kidney Function: A Secondary Analysis of the CREDENCE Randomized Trial.

  2020cites this paper
• Toxinology provides multidirectional and multidimensional opportunities: A personal perspective

  2020cites this paper
• Angiotensin II represses Npr1 expression and receptor function by recruitment of transcription factors CREB and HSF-4a and activation of HDACs

  2020cites this paper
• Cingulate networks associated with gray matter loss in Parkinson's disease show high expression of cholinergic genes in the healthy brain

  2020cites this paper
• Cardiovascular Research

  2020cites this paper
• Dedicated kidney disease‐focused outcome trials with sodium‐glucose cotransporter‐2 inhibitors: Lessons from CREDENCE and expectations from DAPA‐HF, DAPA‐CKD, and EMPA‐KIDNEY

  2020influential citation
• Investigation of Atrial Natriuretic Peptide as A Competitive Inhibitory Candidate Against Wnt/β-Catenin Signalling: A Molecular Dynamics Approach

  2020cites this paper
• Venom natriuretic peptides guide the design of heart failure therapeutics.

  2020cites this paper
• Genetic Ablation and Guanylyl Cyclase/Natriuretic Peptide Receptor-A: Impact on the Pathophysiology of Cardiovascular Dysfunction

  2019influential citation
• Assessing Welfare: Short-Term Responses

  2019cites this paper
• Orthostatic hypotension and novel blood pressure associated gene variants in older adults: data from the TILDA Study.

  2019cites this paper
• Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.

  2019cites this paper
• Stress and Animal Welfare: Key Issues in the Biology of Humans and Other Animals

  2019influential citation
• Ibuprofen and diclofenac impair the cardiovascular development of zebrafish (Danio rerio) at low concentrations.

  2019cites this paper
• Emerging concepts of receptor endocytosis and concurrent intracellular signaling: Mechanisms of guanylyl cyclase/natriuretic peptide receptor-A activation and trafficking.

  2019cites this paper
• ARNi: A Novel Approach to Counteract Cardiovascular Diseases

  2019cites this paper
• Effects of atrial natriuretic peptide on renal function during cardiopulmonary bypass: a randomized pig model.

  2019cites this paper
• Genetic disruption of guanylyl cyclase/natriuretic peptide receptor‐A upregulates renal (pro)renin receptor expression in Npr1 null mutant mice

  2019cites this paper
• Therapeutic progress and knowledge basis about natriuretic peptide system in heart failure.

  2019cites this paper
• Novel therapeutic interventions in cancer treatment using protein and peptide-based targeted smart systems.

  2019cites this paper
• Loop analysis of blood pressure/volume homeostasis

  2019cites this paper
• BNP as a Major Player in the Heart-Kidney Connection

  2019cites this paper
• Atrial natriuretic peptide for treatment of acute kidney injury (AKI) - Initiate an optimal dose early.

  2019cites this paper
• Investigating the roles that G protein-coupled receptor kinase 2 plays in arterial smooth muscle proliferation

  2019cites this paper
• Cholinergic circuit genes in the healthy brain are differentially expressed in regions that exhibit gray matter loss in Parkinson’s disease

  2019cites this paper
• Renal Modulation

  2019cites this paper
• The Protective Role of Natriuretic Peptide Receptor 2 against High Salt Injury in the Renal Papilla.

  2019cites this paper
• Preeminent Role of the Cardiorenal Axis in the Antihypertensive Response to an Arteriovenous Fistula: An In Silico Analysis.

  2019cites this paper
• CANCER THERAPY

  2018cites this paper
• Synthesis, secretion, function, metabolism and application of natriuretic peptides in heart failure

  2018cites this paper
• Emerging pathways of communication between the heart and non-cardiac organs

  2018cites this paper
• Natriuretic Peptides and Normal Body Fluid Regulation.

  2018cites this paper
• Contribution of oxidative stress and growth factor receptor transactivation in natriuretic peptide receptor C-mediated attenuation of hyperproliferation of vascular smooth muscle cells from SHR

  2018cites this paper
• Demands of a Theory for an Aging Mechanism involving a Soft and Hard Electrophile

  2018cites this paper
• Role of the heart in blood pressure lowering during chronic baroreflex activation: insight from an in silico analysis.

  2018cites this paper
• Renal function in cardiac surgery - Clinical and experimental studies

  2018cites this paper
• Pregnancy-Induced Physiologic Alterations

  2018cites this paper
• Altered vasopressin and natriuretic peptide levels in a rat model of spinal cord injury: implications for the development of polyuria.

  2018cites this paper
• The expression of natriuretic peptide receptors in developing zebrafish embryos.

  2018cites this paper
• Natriuretic peptide receptor-C activation attenuates angiotensin II-induced enhanced oxidative stress and hyperproliferation of aortic vascular smooth muscle cells

  2018cites this paper
• CHARACTERIZATION OF SPONTANEOUS HYPERTENSION IN CHLOROCEBUS AETHIOPS SABAEUS, THE AFRICAN GREEN MONKEY

  2018cites this paper
• Molecular and genetic aspects of guanylyl cyclase natriuretic peptide receptor-A in regulation of blood pressure and renal function.

  2018influential citation
• Tumor necrosis factor-a inhibits store-mediated Ca21 entry in the human hepatocellular carcinoma cell line HepG2

  2017cites this paper
• Getting to the Heart of the Matter: Review of Treatment of Cardiorenal Syndrome.

  2017cites this paper
• Decoding the molecular switches of natriuretic peptides which differentiate its vascular and renal functions.

  2017cites this paper
• Characterisation of synaptic transmission and angiotensin II type 1A receptor activity at nucleus of the solitary tract neurons

  2017cites this paper
• Artificial Syndrome of Inappropriate Antidiuresis Model as Potential Use for Diagnostic and Therapeutic Strategies

  2017cites this paper
• Clathrin-dependent internalization, signaling, and metabolic processing of guanylyl cyclase/natriuretic peptide receptor-A

  2017cites this paper
• Recombinant production, purification and characterization of vessel dilator in E. coli.

  2017cites this paper
• Natriuretic peptide receptor‐C‐mediated attenuation of vascular smooth muscle cell hypertrophy involves Gqα/PLCβ1 proteins and ROS‐associated signaling

  2017cites this paper
• Atrial natriuretic peptide and brain natriuretic peptide changes after epicardial percutaneous left atrial appendage suture ligation using LARIAT device.

  2017cites this paper
• Association of NPR3 polymorphism with risk of essential hypertension in a Chinese population

  2017cites this paper
• The renal and cardiovascular effects of natriuretic peptides.

  2017influential citation